US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist
  • 1.250
  • +0.060+5.02%
Close May 2 16:00 ET
  • 1.230
  • -0.020-1.60%
Post 20:01 ET
13.39MMarket Cap-1.05P/E (TTM)

Marker Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
99.06%6.59M
99.06%6.59M
0
0
0
3.31M
3.31M
0
0
0
Operating revenue
99.06%6.59M
99.06%6.59M
--0
--0
--0
--3.31M
--3.31M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-23.75%11.12M
31.44%3.86M
-25.01%2.4M
-44.17%2.31M
-40.85%2.55M
-26.32%14.58M
-3.32%2.94M
-45.08%3.2M
-21.53%4.13M
-56.00%4.31M
Selling and administrative expenses
-43.26%4.24M
-25.42%1.03M
-39.50%854.68K
-54.66%1.14M
-43.80%1.22M
-34.05%7.48M
-14.76%1.38M
-56.32%1.41M
-19.66%2.52M
-41.94%2.17M
-General and administrative expense
-43.26%4.24M
-25.42%1.03M
-39.50%854.68K
-54.66%1.14M
-43.80%1.22M
-34.05%7.48M
-14.76%1.38M
-56.32%1.41M
-19.66%2.52M
-41.94%2.17M
Research and development costs
29.29%13.47M
94.33%5.09M
69.74%3.47M
-1.79%2.34M
-23.74%2.58M
-12.96%10.42M
19.93%2.62M
-43.07%2.04M
-18.67%2.38M
-51.94%3.38M
Other operating expenses
-99.06%-6.59M
-113.13%-2.25M
-647.66%-1.93M
-53.31%-1.17M
-0.79%-1.24M
5.76%-3.31M
-39.17%-1.06M
74.23%-257.61K
3.52%-762.66K
-28.00%-1.23M
Operating profit
59.83%-4.53M
631.14%2.73M
25.01%-2.4M
44.17%-2.31M
40.85%-2.55M
43.05%-11.27M
112.29%373.34K
45.08%-3.2M
21.53%-4.13M
56.00%-4.31M
Net non-operating interest income expense
-18.95%437.01K
-63.37%73.75K
-57.96%91.68K
228.93%115.39K
84.51%156.2K
117.35%539.16K
84.02%201.34K
118.63%218.09K
-1.97%35.08K
2,615.88%84.65K
Non-operating interest income
-18.95%437.01K
-63.37%73.75K
-57.96%91.68K
228.93%115.39K
84.51%156.2K
117.35%539.16K
84.02%201.34K
118.63%218.09K
-1.97%35.08K
2,615.88%84.65K
Other net income (expense)
Income before tax
61.88%-4.09M
387.82%2.8M
22.59%-2.31M
46.51%-2.19M
43.36%-2.39M
45.74%-10.73M
118.88%574.68K
47.93%-2.98M
21.67%-4.1M
57.37%-4.22M
Income tax
1,259.27%49.95K
3.68K
Net income
-30.28%-10.73M
-36.91%-3.84M
22.59%-2.31M
-187.16%-2.19M
51.83%-2.39M
72.48%-8.24M
27.31%-2.8M
56.91%-2.98M
127.21%2.52M
49.88%-4.97M
Net income continuous Operations
23.60%-10.73M
-40.05%-3.84M
22.59%-2.31M
46.51%-2.19M
43.36%-2.39M
28.97%-14.05M
9.96%-2.74M
47.93%-2.98M
21.67%-4.1M
57.37%-4.22M
Net income discontinuous operations
--0
--0
--0
--0
--0
157.21%5.81M
92.26%-62.94K
--0
264.90%6.61M
---742.75K
Minority interest income
Net income attributable to the parent company
-30.28%-10.73M
-36.91%-3.84M
22.59%-2.31M
-187.16%-2.19M
51.83%-2.39M
72.48%-8.24M
27.31%-2.8M
56.91%-2.98M
127.21%2.52M
49.88%-4.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-30.28%-10.73M
-36.91%-3.84M
22.59%-2.31M
-187.16%-2.19M
51.83%-2.39M
72.48%-8.24M
27.31%-2.8M
56.91%-2.98M
127.21%2.52M
49.88%-4.97M
Basic earnings per share
-26.60%-1.19
-31.25%-0.42
23.53%-0.26
-186.21%-0.25
52.63%-0.27
73.74%-0.94
28.89%-0.32
59.04%-0.34
126.13%0.29
52.10%-0.57
Diluted earnings per share
-26.60%-1.19
-31.25%-0.42
23.53%-0.26
-186.21%-0.25
52.63%-0.27
73.74%-0.94
28.89%-0.32
59.04%-0.34
126.13%0.29
52.10%-0.57
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 99.06%6.59M99.06%6.59M0003.31M3.31M000
Operating revenue 99.06%6.59M99.06%6.59M--0--0--0--3.31M--3.31M--0--0--0
Cost of revenue
Gross profit
Operating expense -23.75%11.12M31.44%3.86M-25.01%2.4M-44.17%2.31M-40.85%2.55M-26.32%14.58M-3.32%2.94M-45.08%3.2M-21.53%4.13M-56.00%4.31M
Selling and administrative expenses -43.26%4.24M-25.42%1.03M-39.50%854.68K-54.66%1.14M-43.80%1.22M-34.05%7.48M-14.76%1.38M-56.32%1.41M-19.66%2.52M-41.94%2.17M
-General and administrative expense -43.26%4.24M-25.42%1.03M-39.50%854.68K-54.66%1.14M-43.80%1.22M-34.05%7.48M-14.76%1.38M-56.32%1.41M-19.66%2.52M-41.94%2.17M
Research and development costs 29.29%13.47M94.33%5.09M69.74%3.47M-1.79%2.34M-23.74%2.58M-12.96%10.42M19.93%2.62M-43.07%2.04M-18.67%2.38M-51.94%3.38M
Other operating expenses -99.06%-6.59M-113.13%-2.25M-647.66%-1.93M-53.31%-1.17M-0.79%-1.24M5.76%-3.31M-39.17%-1.06M74.23%-257.61K3.52%-762.66K-28.00%-1.23M
Operating profit 59.83%-4.53M631.14%2.73M25.01%-2.4M44.17%-2.31M40.85%-2.55M43.05%-11.27M112.29%373.34K45.08%-3.2M21.53%-4.13M56.00%-4.31M
Net non-operating interest income expense -18.95%437.01K-63.37%73.75K-57.96%91.68K228.93%115.39K84.51%156.2K117.35%539.16K84.02%201.34K118.63%218.09K-1.97%35.08K2,615.88%84.65K
Non-operating interest income -18.95%437.01K-63.37%73.75K-57.96%91.68K228.93%115.39K84.51%156.2K117.35%539.16K84.02%201.34K118.63%218.09K-1.97%35.08K2,615.88%84.65K
Other net income (expense)
Income before tax 61.88%-4.09M387.82%2.8M22.59%-2.31M46.51%-2.19M43.36%-2.39M45.74%-10.73M118.88%574.68K47.93%-2.98M21.67%-4.1M57.37%-4.22M
Income tax 1,259.27%49.95K3.68K
Net income -30.28%-10.73M-36.91%-3.84M22.59%-2.31M-187.16%-2.19M51.83%-2.39M72.48%-8.24M27.31%-2.8M56.91%-2.98M127.21%2.52M49.88%-4.97M
Net income continuous Operations 23.60%-10.73M-40.05%-3.84M22.59%-2.31M46.51%-2.19M43.36%-2.39M28.97%-14.05M9.96%-2.74M47.93%-2.98M21.67%-4.1M57.37%-4.22M
Net income discontinuous operations --0--0--0--0--0157.21%5.81M92.26%-62.94K--0264.90%6.61M---742.75K
Minority interest income
Net income attributable to the parent company -30.28%-10.73M-36.91%-3.84M22.59%-2.31M-187.16%-2.19M51.83%-2.39M72.48%-8.24M27.31%-2.8M56.91%-2.98M127.21%2.52M49.88%-4.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -30.28%-10.73M-36.91%-3.84M22.59%-2.31M-187.16%-2.19M51.83%-2.39M72.48%-8.24M27.31%-2.8M56.91%-2.98M127.21%2.52M49.88%-4.97M
Basic earnings per share -26.60%-1.19-31.25%-0.4223.53%-0.26-186.21%-0.2552.63%-0.2773.74%-0.9428.89%-0.3259.04%-0.34126.13%0.2952.10%-0.57
Diluted earnings per share -26.60%-1.19-31.25%-0.4223.53%-0.26-186.21%-0.2552.63%-0.2773.74%-0.9428.89%-0.3259.04%-0.34126.13%0.2952.10%-0.57
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More